ABOUT TIDETRON
Founded in 2021 by Dr. Zhiqian Zhang - a Generation Z, Tidetron Bioworks Technology Co., Ltd. is one of the world’s first synthetic bio-manufacturing platforms to realize mass production of various substances. In just 10 months, we have been financed over $100 million and recognized as a new star of synthetic biology worldwide.
We adhere to the principle of "It’s growing" and is committed to synthetic biotechnology innovation to meet people's new requirements on medicine, food, cosmetics, safety. Now we have established a chain from R&D to production and built our unique Tidetron Altra platform-based strain library and component library. We have made absolute breakthroughs in mass production and universality. Our factory could provide customized production, with an annual production capacity exceeding 10,000 tons.
At present, there are more than 30 substances on sale, including peptides, erythritol, and bulk commodities. We also provide integrated enterprise-universities-researches solutions in skin care, food and beverage, household cleaning, biomedicine, etc.
We built a "quick response" system with its exclusive technology, which has broken the bottleneck in transforming and applying. Efficient mass production technology makes the traditional mode of production enter "environmental protection mutation", and the industrial chain realizes a green upgrade. In the trend of green life, Tidetron, which influences Environmental, Social and Governance (ESG) and end products in the industry, is turning synthetic biology into the fundamental force that changes traditional production and making more people achieve the carbon peaking and carbon neutrality goals in daily life.
DEVELOPMENT HISTORY
The 1st Trophy
Zhiqian Zhang, the founder of Tidetron, began to devote himself to the research after being exposed to synthetic biology during his Ph.D. at Sun Yat-sen University. As a representative of Chinese students, he participated in iGEM and won three awards: the Gold Medal in the Finals, the Best Therapeutics Project and the Best New Composite Part.
The 1st Laboratory
Zhiqian Zhang realized that synthetic biology has great potential, while mass production and commercial construction are common problems of the industry. He also realized that the most important thing is how to apply synthetic biology to real industrial production. Thus, he began to set up R&D laboratories with the goal of mass production.
The 1st Victory against Difficulty
After four years of research, the Tidetron Altra platform-based strain library with the value of universal application was successfully built in the laboratory, a milestone progress involved in mass production and universality.
The 1st factory
Tidetron’s intelligent factory was put into use, and the customized intelligent fermentation system provided ultra-mild production mode with low energy consumption, less pollution and low carbon emission.
The 1st Transcendence
The number of mass-produced substances reaches more than 30, covering various fields such as specialized skin care, food and beverage, household cleaning, biomedicine, etc. We are the first to realize multi-substance mass production in the industry.
The 1st Cooperation
We take the strategy of scientific research driving production and create a enterprises-universities-researches model. Tidetron has successively carried out joint research and practical cooperation with scientific research units such as Sun Yat-sen University, Jiangnan University, and the Key Laboratory of Materials Chemical Engineering, etc.
The 1st over $100 million financing
Four rounds of financing were completed within 10 months. The investment institutions included Unity Ventures, ZhenFund, Legend Capital, IDG Capital, etc., accumulating financing that exceeds $100 million.
The 1st hardware upgrade
The laboratory was expanded to 2,000 square meters. The hardware equipment was upgraded again, and the members of the scientific research family increased exponentially; We further improved the research and production space in a lively atmosphere, and keep chasing technological innovation.
Launched Tidetron Tao automated R&D platform.
The built-in strain and component libraries, iTidetron AI engine, etc., further open up the DBTL cycle of synthetic biology, greatly enhance the R&D efficiency, and link every step of R&D and production. Our solid technology development and upgrading iterations have made it possible for us to rapidly develop cross-disciplinary substances and put them into production on the ground.
Approved to build "Guangdong Synthetic Biological Industry Engineering and Technology Research Center".
Stage Creative continues to promote the rapid transformation and application of synthetic biology research results, and works closely with partners in the academic community, peers, and industry to promote in-depth cooperation between industry, academia, and research, and to jointly assist in the development of new quality productivity of biomanufacturing.
Founder & CEO
Domestic Synthetic Biology Emerging Researchers
D. student in clinical medicine at Sun Yat-sen University School of Medicine, Sun Yat-sen University, and has been engaged in basic medical and biological research for many years. He has visited Yale University School of Medicine, as well as conducted research at South China Stem Cell Research Center, Zhongshan Ophthalmic Center, and Cardiovascular Center of Yale University.
In 2016, he won the Gold Award, Best Therapeutic Award, and Best Novel Constituent Biological Module Award of the International Genetically Engineered Machine Competition (iGEM), and has been invited to be the mentor of the synthetic biology team of iGEM Sun Yat-sen University of Medical Sciences as well as a judge of the iGEM; He was listed on the Forbes China "30 under 30" in 2021, and was selected as the cover person of "30 under 30" in 2024 in Asia. He has been listed on the "30 under 30" of Forbes China 2021 and selected as the cover of "30 under 30" of Forbes Asia 2024.
Currently, he is a member of the Industrial Specialty Branch of the Chinese Society of Biochemistry and Molecular Biology, and Deputy Director of the Specialized Committee of Guangzhou Synthetic Biology Industry and Technology Alliance.
Zhiqian Zhang
founder, CEO
Chinese 
English 
